suramin - CISMeF

Preferred Label : suramin;

MeSH definition : A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. (From AMA Drug Evaluations Annual, 1992, p1643) It has also been shown to have potent antineoplastic properties.;

CISMeF synonym : 129-46-4 (Suramin sodium);

MeSH hyponym : naganol; germanin; naphuride; suramin, monosodium salt; suramin sodium; naganin; moranil; Sodium, Suramin; Suramin, Hexasodium Salt; Hexasodium Salt Suramin; Salt Suramin, Hexasodium; Monosodium Salt Suramin; Salt Suramin, Monosodium;

MeSH CAS label : 1,3,5-Naphthalenetrisulfonic acid, 8,8'-(carbonylbis(imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino))bis-;

MeSH Related Number : suramin sodium; suramin, monosodium salt; 129-46-4 (hexa-Na salt); 145-63-1 (Suramin); 3308-30-3 (mono-Na salt); 89521262IH;

Registry Number MeSH : 145-63-1;

Related CAS MeSH : 3308-30-3 (Suramin, monosodium salt); 89521262IH (Suramin sodium);

Wikipedia link : https://en.wikipedia.org/wiki/Suramin;

Is substance : O;

UNII : 6032D45BEM;

InChIKey : FIAFUQMPZJWCLV-UHFFFAOYSA-N;

Détails

Origin ID

D013498;

UMLS CUI

C0038880;

ATC code(s)
- suramin sodium [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Suramin (substance) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Suramin [NCIt concept]
Pharmacological action(s)
- antinematodal agents [MeSH Descriptor]
- antineoplastic agents [MeSH Descriptor]
- trypanocidal agents [MeSH Descriptor]
Record concept(s)
- germanin [MeSH concept]
- moranil [MeSH concept]
- naganin [MeSH concept]
- naganol [MeSH concept]
- naphuride [MeSH concept]
- suramin [MeSH concept]
- suramin sodium [MeSH concept]
- suramin, monosodium salt [MeSH concept]
Related MeSH Supplementary Concept(s)
- 6-((4,6,8-trisulfo-1-naphthyl)iminocarbonyl-1,3-(4-methylphenylene)iminocarbonyl-1,3-phenyleneazo)pyridoxal-5'-phosphate [MeSH Supplementary Concept]
- 8,8',8'',8'''-(carbonylbis(imino-5,13-benzenetriyl-bis(carbonylimino)))tetrakisnaphthalene-1,3,5-trisulfonic acid [MeSH Supplementary Concept]
- NF 279 [MeSH Supplementary Concept]
- NF023 [MeSH Supplementary Concept]
- NF157 compound [MeSH Supplementary Concept]
- NF676 compound [MeSH Supplementary Concept]
- XAMR 0721 [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Product containing suramin (medicinal product) [SNOMED CT concept]
- Suramin [NCIt concept]
- Suramin (substance) [SNOMED CT concept]
Validated automatic mappings to BTNT
- Suramin sodium [ICD-11 Extension code]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients